Fusion Antibodies PLC (FAB) — Defensive Interval Ratio
Fusion Antibodies PLC (FAB) has a Defensive Interval Ratio of 410 days as of September 2025. Defensive assets of GBX868.00K (cash GBX-, short-term investments GBX-, receivables GBX868.00K) cover 410 days of daily cash needs of GBX2.12K/day. Check FAB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Fusion Antibodies PLC Defensive Interval Ratio (2006–2025)
This chart shows how Fusion Antibodies PLC's Defensive Interval Ratio has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 410 days, meaning defensive assets of GBX868.00K can fund 410 days of operations without new revenue. Also explore Fusion Antibodies PLC (FAB) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Fusion Antibodies PLC (2006–2025)
The table below presents the year-by-year Defensive Interval Ratio for Fusion Antibodies PLC from 2006 to 2025, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Fusion Antibodies PLC (FAB) total market value.
| Year | DIR (days) | Defensive Assets (GBX) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 195 days | GBX332.00K | GBX1.71K/day | GBX- | GBX- | ▼ -154 days |
| 2024 | 348 days | GBX557.00K | GBX1.60K/day | GBX- | GBX- | ▼ -48 days |
| 2023 | 396 days | GBX953.00K | GBX2.41K/day | GBX- | GBX- | ▼ -102 days |
| 2022 | 498 days | GBX1.65 Million | GBX3.31K/day | GBX- | GBX- | ▼ -66 days |
| 2021 | 564 days | GBX1.54 Million | GBX2.73K/day | GBX- | GBX- | ▲ +223 days |
| 2020 | 341 days | GBX925.00K | GBX2.71K/day | GBX- | GBX- | ▼ -153 days |
| 2019 | 495 days | GBX1.08 Million | GBX2.18K/day | GBX- | GBX- | ▼ -103 days |
| 2018 | 597 days | GBX933.13K | GBX1.56K/day | GBX- | GBX- | ▲ +121 days |
| 2017 | 477 days | GBX561.84K | GBX1.18K/day | GBX- | GBX- | ▲ +243 days |
| 2016 | 233 days | GBX250.19K | GBX1.07K/day | GBX- | GBX- | ▼ -178 days |
| 2015 | 412 days | GBX204.94K | GBX497.72/day | GBX- | GBX- | ▲ +306 days |
| 2014 | 106 days | GBX86.51K | GBX815.25/day | GBX- | GBX- | ▼ -26 days |
| 2013 | 133 days | GBX92.09K | GBX694.70/day | GBX- | GBX- | ▼ -77 days |
| 2012 | 210 days | GBX243.00K | GBX1.16K/day | GBX- | GBX- | ▼ -231 days |
| 2011 | 441 days | GBX437.00K | GBX991.78/day | GBX- | GBX- | ▲ +161 days |
| 2010 | 279 days | GBX215.00K | GBX769.86/day | GBX- | GBX- | ▲ +52 days |
| 2009 | 227 days | GBX373.00K | GBX1.64K/day | GBX- | GBX- | ▼ -73 days |
| 2008 | 300 days | GBX340.00K | GBX1.13K/day | GBX- | GBX- | ▼ -127 days |
| 2007 | 427 days | GBX456.00K | GBX1.07K/day | GBX- | GBX- | ▼ -7 days |
| 2006 | 434 days | GBX265.00K | GBX610.96/day | GBX- | GBX- | — |